troglitazone has been researched along with bromochloroacetic acid in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Smith, B; Southgate, J; Stahlschmidt, J; Stower, M; Varley, CL | 1 |
Bergum, N; Garrett, SH; Knutson, P; Mehus, AA; Sens, DA; Sens, MA; Shrestha, S; Somji, S; Zhou, XD | 1 |
2 other study(ies) available for troglitazone and bromochloroacetic acid
Article | Year |
---|---|
Activation of peroxisome proliferator-activated receptor-gamma reverses squamous metaplasia and induces transitional differentiation in normal human urothelial cells.
Topics: Cell Differentiation; Chromans; Cloning, Molecular; DNA, Complementary; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Humans; Immunoblotting; Immunohistochemistry; Keratins; Metaplasia; Microscopy, Fluorescence; Quinazolines; Receptors, Cytoplasmic and Nuclear; Ribonucleases; RNA, Messenger; Signal Transduction; Thiazolidinediones; Transcription Factors; Troglitazone; Urothelium | 2004 |
Activation of PPARĪ³ and inhibition of cell proliferation reduces key proteins associated with the basal subtype of bladder cancer in As3+-transformed UROtsa cells.
Topics: Animals; Arsenites; Biomarkers, Tumor; Cell Line, Tumor; Cell Proliferation; Down-Regulation; ErbB Receptors; Hepatocyte Nuclear Factor 3-alpha; Humans; Keratins; Mice; Mice, Nude; PPAR gamma; Quinazolines; Transcription Factors; Transcriptome; Transplantation, Heterologous; Troglitazone; Up-Regulation; Urinary Bladder Neoplasms | 2020 |